Product Information
MOUNJARO 2.5 MG/0.5 ML PEN is a brand product labeled by Eli Lilly and Company, priced at $538.6419 per ML under NDC 00002150680. Its NADAC has been published 210 times since Aug 17, 2022.
FDA first approved this application on May 13, 2022.
Strength
2.5 mg/.5mL
Manufacturer
Eli Lilly and CompanyNDC
00002150680
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
TIRZEPATIDEApproval Type
New Drug (NDA)
FDA Application
NDA215866FDA Approved
5/13/2022
On Market Since
5/13/2022
Pharmacological Classes
Price Statistics
The NADAC for MOUNJARO 2.5 MG/0.5 ML PEN has been published 210 times since Aug 17, 2022, and over the history we have for it it has risen 15.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $538.6419 per ML |
|---|---|
| All-time high | $538.7954 (May 13, 2026) |
| All-time low | $467.3658 (Aug 17, 2022) |
| 52-week high | $538.7954 |
| 52-week low | $523.0366 |
| Median price | $515.8135 |
| Average price | $510.1851 |
| Largest weekly change | +5.0% (Jan 11, 2023) |
| Weeks tracked | 210 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOUNJARO 2.5 MG/0.5 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for MOUNJARO 2.5 MG/0.5 ML PEN, manufactured by Eli Lilly and Company, is $538.6419 per ML (NDC 00002150680), effective Aug 19, 2026.
How has the price of MOUNJARO 2.5 MG/0.5 ML PEN changed over time?
Over the history we have for it, the NADAC for MOUNJARO 2.5 MG/0.5 ML PEN has risen 15.3%. It has been tracked across 210 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for MOUNJARO 2.5 MG/0.5 ML PEN?
Since Aug 17, 2022, the NADAC for MOUNJARO 2.5 MG/0.5 ML PEN has ranged from a low of $467.3658 (Aug 17, 2022) to a high of $538.7954 (May 13, 2026), with a median of $515.8135 per ML.
Are there cheaper alternatives to MOUNJARO 2.5 MG/0.5 ML PEN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZEPBOUND 2.5 MG/0.5 ML PEN, is $526.1137 per ML — about 2% below MOUNJARO 2.5 MG/0.5 ML PEN.
Who manufactures MOUNJARO 2.5 MG/0.5 ML PEN?
MOUNJARO 2.5 MG/0.5 ML PEN (NDC 00002150680) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.